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ABSTRACT
At weaning, piglets are more susceptible to infectious diseases, being respiratory syndromes
one of the most frequent conditions. Fosfomycin is indicated for the treatment of a variety of
porcine bacterial pathogens, with MIC90 ranging between 0.25-0.50 µg mLG1. Fosfomycin exhibits
a time-dependent killing. Thus, killing of bacteria occurs when its concentrations remain constantly
above the MIC. Fosfomycin concentrations in respiratory cells and epithelial lining fluid of pigs
have already been studied. Although, fosfomycin showed clinical efficacy in the treatment of
pulmonary diseases, concentrations in alveolar macrophages (biophase for facultative and obligate
intracellular microorganisms) have not been established in any species. The present study
determined the intracellular concentrations of disodium  fosfomycin  in  alveolar  macrophages
after  a  single  IM  dose  of  15 mg kgG1  in  the  gluteal  muscle.  Concentrations   ranged   from
0.14-1.52 µg mLG1, being lower than those found in epithelial lining fluid (49.03%) and respiratory
cells (54.48%). The Cmax was 1.52 µg mLG1 and Tmax was 4 h. Concentrations exceeded the MIC90 for
most pathogens of importance in pig production for up to six hours (T>MIC = 6 h). Therefore,
fosfomycin may be useful in the treatment of lung infections caused by facultative intracellular
microorganisms.
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INTRODUCTION
In pig production, weaning is considered as a critical period for piglets. It is characterized by
a decrease in food intake that leads to a status of under nutrition, affecting other aspects of animal
physiology and metabolism (Dirkzwager et al., 2005). During this period, animals are more
susceptible to infectious diseases (Nabuurs et al., 1993). Respiratory syndromes are one of the most
frequent conditions that occur at weaning. They are a common cause of morbidity and mortality.
Therefore, they are considered one of the most significant problems in modern intensive swine
production systems (Gardner and Hird, 1990; Galina et al., 1994; Done and Paton, 1995;
Christensen et al., 1999; Thanawongnuwech  et  al.,  2000;  Carr,  2001;  Cloutier  et al.,  2003;
Dosen et al., 2007). The intracellular and interstitial fluids are the pulmonary biophase of
facultative microorganisms such as Mycoplasma hyopneumoniae, Bordetella bronchisceptica,
Salmonella cholerasuis,  Pasteurella  multocida  and  Streptococcus  spp. Different  antibiotics  have
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been used for decades to reduce pathogen infections in pigs.  For  this  reason,  many  bacteria  have
become resistant to the most frequently used  antimicrobials  (Dirkzwager  et al.,  2005).
Fosfomycin (FOS) (cis-1, 2-epoxyphosphonic acid), a broad-spectrum antibiotic structurally
unrelated to other classes of antimicrobial agents, is used in swine production in Central and South
America and in various Asian countries. The FOS is indicated for the treatment of a variety of
porcine bacterial pathogens (Haemophilus parasuis, Streptococcus suis, Pasteurella multocida,
Bordetella bronchiseptica, Staphylococcus hyicus and Escherichia coli), which are usually associated
with stress and/or viral diseases. The minimum inhibitory concentration required to inhibit the
growth of 90% of the microorganisms (MIC90) for most of the important pathogens in swine
production has been established as 0.25-0.5 µg mLG1 (Fernandez et al., 1995).  The FOS exhibits
a time-dependent killing. Thus, killing of bacteria occurs when its concentrations remain constantly
above the MIC (Aliabadi and Lees, 1997; Toutain et al., 2002). In this regard, for an antibiotic to
be effective against relevant pathogens, it is essential to reach concentrations higher than the MIC
at the site of action (Nix et al., 1991; Schentag and Ballow, 1991; Toutain et al., 2002).
The  FOS  penetration  has  been  demonstrated  in   phagocytic   cells,   where   it   reaches
high  concentrations,  showing  an  intracellular   activity   close   to   that   of  rifampicin
(Trautmann et al., 1992). Antibiotic penetration does not alter the ability of ingestion and
destruction by these cells, as it has been demonstrated by in  vitro  studies  (Hoger,  1985).
Morikawa et al. (1993) and Honda et al. (1998) have shown that FOS has immune-modulatory
effects on lymphocytes. Similarly, Krause et al. (2001) studied the effect of FOS on neutrophil
function and showed that the destruction of microorganisms is increased when incubated with the
antibiotic. Perez et al. (2013) studied FOS penetration in swine intestinal cells (IPEC-J2) and they
found that FOS concentrations exceed the MIC90 for the most important pathogens in swine
intestinal infections. Therefore, it is apparent that this antibiotic is an alternative for the treatment
of intestinal infections in pigs. Martinez et al. (2013) studied the penetration of FOS into IPEC-J2
cells in the presence or absence of the mycotoxin deoxynivalenol (DON) and they concluded that
the non-toxic concentration of DON on IPEC-J2 cells after short-term exposure interferes with the
pharmacokinetics of the antibiotic. Perez et al. (2012) showed that FOS concentrations in HEP-2
cells, a respiratory cell line, exceeded the MIC90 for the pathogens which frequently cause swine
respiratory infections. Therefore, it is apparent that FOS is an alternative for the treatment of
intracellular respiratory infections in pigs. Furthermore, determined FOS penetration in HEP-2
cell cultures and their interactive effect with DON and they concluded that the presence of the
mycotoxin does not alter the intracellular distribution  of  the  antibiotic. On  the  other  hand,
Soraci et al. (2012) demonstrated that FOS concentrations in Epithelial Lining Fluid (ELF) were
above the MIC90 value for Streptococcus up to 8 h post IM administration of 15 mg kgG1 of FOS in
weaning piglets.
The FOS showed clinical efficacy in the treatment of pulmonary diseases. Nevertheless,
concentrations in Alveolar Macrophages (AM) (biophase for facultative and obligate intracellular
microorganisms) have not been established in any species yet. Assuming that the determination
of FOS concentration in the biophases represents the key parameter for establishing efficacy of
antibiotics, the objective of this study was to characterize the penetrating capacity of FOS in
alveolar macrophages and its relationship with serum concentrations in weaning piglets.
MATERIALS AND METHODS
Six weaning piglets (three males and three females), clinically healthy, 25-28 days of age, were
used in this assay. Disodium FOS was supplied by Bedson Laboratories S.A.,  Pilar,   Buenos  Aires,
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Argentina. It was dissolved in a 10% sodium citrate solution (pH: 6.8). To minimize stress and
facilitate blood sampling, a permanent long catheter was placed in the left external jugular vein
of each piglet. The study was carried out according to the rules of ethics approval of the
Experimental Ethics Committee of the Faculty of Veterinary Science, UNCPBA, Argentina.
Alveolar macrophages intracellular concentrations of disodium FOS after a single IM dose of
15  mg kgG1 in the gluteal muscle were evaluated. Macrophages were obtained from bronchoalveolar
lavage fluid (BALF) samples. To procure BALF samples, a flexible fiber optic bronchoscope
(Olympus BF- P20D) was used. The bronchoscope  was  pushed  into  the  bronchus  trachealis
which leads into the  right  cranial  lung  lobe  (Shields  and  Riedler,  2000;  Baltes  et  al.,  2001;
Scollo et al., 2011; Soraci et al., 2011). Seven milliliters of 0.9% sterile saline solution (prewarmed
to 30°C) were introduced and recovered by using a vacuum pump  aspiration  with  a  maximum 
of  15 kPa (Shields and Riedler, 2000; Baltes et al., 2001). A range between 15 and 18 mL of BALF
were obtained after repeating the washings three times (Shields and Riedler, 2000). The procedure
of instillation  and  collection  was  completed  in  <1  min  (Baughman  et  al.,  1983; Dohn and
Baughman, 1985; Rennard et al., 1986; Grigg et al., 1991; Lamer et al., 1993; Baughman, 1997;
Mombarg et al., 2002). The BALF samples were collected after 1, 2, 3 and 6 h of IM administration
of FOS. Lavage sample were immediately centrifuged at 2000 rpm for 10 min and the supernatant
was separated from the pellets. The BALF samples, stored in 1.5 mL tubes, were centrifuged at 4°C
and 3500 rpm for 15 min. Supernatants were removed and the pellets were resuspended in 500 µL
of HPLC water. Ten microliter of the resuspended pellets were taken and mixed with 10 µL of
trypan blue to determine cell viability. Cell count was performed in a Neubauer chamber. Samples
were ultrasonicated for 30 min to release FOS from AM. Vials were filtered  with  0.22 µm  filters 
and  finally  analyzed  by HPLC-MS/MS. Since, the number of cells in each sample was different,
results were extrapolated to 400,000 cells, corresponding to the number of macrophages present
in a  well   monolayer  of  a 6-well plate. To calculate the final intracellular concentrations of FOS
in AM, it was considered that the pellet was resuspended in 500 µL of HPLC water and that there
is an intracellular water volume of 1.50 µL in 400,000 macrophages (dilution factor: 0.5015).
The FOS concentrations  were  measured  using  a  High  Performance  Liquid
Chromatography-Mass-Mass Spectrometry (HPLC-MS'MS) according to the method determined
by Soraci et al. (2012). The HPLC-MS/MS (Thermo Electron Corporation) system consisted of a
Finnigan Surveyor autosampler and a quaternary pump Finnigan MS. The detector was a mass
spectrometer quantum triple quadrupole discovery thermo max, equipped with an ESI source. The
nitrogen used as nebulizer gas and envelope was obtained by a nitrogen generator peak scientific
(Inchinnan). Data processing was performed using the Xcalibur software, also purchased from
Thermo. A workstation Turbo Vap (caliper) with bath temperature control and airflow was used
for solvent evaporation. The mass spectrometer was operated in the negative ionization mode. The
adjustment parameters were optimized with individual aqueous solutions of 10 mg mLG1  FOS. An
injection pump directly infused solutions to ion source, while the mobile phase was delivered from
the LC pump via a T-connection to give the corresponding chromatographic flow rate. The spray
voltage  was  set  to  3800  eV,  the  capillary  temperature  was  350°C.  Argon (purity 99.99%) at
1.6 m torr was used for Collision-Induced Dissociation (CID) in the collision cell. The CID energy
source was set at -8 eV. Detection and quantification of FOS was achieved by single reaction
monitoring of the transitions m/z 137679 with optimized collision energy of 25. Separation was
performed on a Phenomenex CN (cyano) (411 Madrid Avenue Torrance, CA90501-1430, USA),
stationary phase, 4.6×75 mm id, 5 µm column.  The  mobile  phase  consisted  of  acetonitrile:  water
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20:80 isocratic mode at a flow rate of 100 µL minG1. The column was maintained at 30°C. The
samples were kept at 10°C in the autosampler. The injection volume of the sample was 20 µL and
the chromatographic run was 6 min.
RESULTS
Concentrations ranged from 0.14-1.52 µg mLG1. The Cmax was 1.52 µg mLG1 and Tmax was 4 h.
Table 1 shows FOS average intracellular concentrations found for each sampling time and some
pharmacokinetics parameters (Tmax; Cmax). Figure 1 shows FOS average intracellular
concentrations in AM after an IM administration of disodium FOS at 15 mg kgG1 in weaning
piglets.
DISCUSSION
Intracellular penetration, accumulation and disposition of antibacterial agents are crucial for
effective treatment of infections caused by intracellular bacteria. Intracellular concentrations and
locations of both antibacterials and bacteria remain poorly understood and further research is
needed to establish the importance of these concepts (Butts, 1994). Measurement of antibiotic
concentrations achieved in lung parenchyma, ELF, bronchial mucosa of bronchial secretions has
shown variable levels for the same drug. Many respiratory infections are caused by obligate or
facultative intracellular pathogens, which may be eradicated as a result of drug intracellular
penetration and accumulation, as shown in several models of phagocytic cells and as a result of
intracellular antibacterial activities (Bergogne-Berezin, 1995). In previous works from our research
group, disodium FOS concentrations in serum (Soraci et al., 2011),  respiratory  cells (HEP-2)
(Perez et al., 2012) and ELF (Soraci et al., 2011) have been determined. Considering our previous
studies, it was found that FOS concentrations were significantly lower (p<0.05) in AM than  in ELF
Table 1: FOS average intracellular concentrations and standard deviations found for each sampling time and some pharmacokinetics
parameters (Tmax; Cmax) in AM after IM administration of disodium FOS at 15 mg kgG1 in weaning piglets
Time (h) FOS average concentration (µg mLG1) SD
1 0.15 0.01
2 0.45 0.02
3 0.60 0.04
4* 1.52^ 0.02
6 1.04 0.01
FOS: Fosfomycin, SD: Standard deviation, AM: Alveolar macrophages
Fig. 1: Fosfomycin average intracellular concentrations (+1 SD) in AM after IM administration of
disodium Fosfomycin at 15 mg kgG1 in weaning piglets
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Fig. 2: Differences between fosfomycin concentrations (mean +1 SD) in AM, ELF and HEP-2 cells.
ELF and HEP-2 cells FOS intracellular concentrations were determined on previous works
of our research group (Soraci et al., 2012; Perez et al., 2012)
after the IM administration of disodium FOS at a dose of 15 mg kgG1 at every sampling time points.
However, the intracellular concentrations in AM correspond to 49.03% of the concentration 
achieved in bronchial fluid (AM: 1.52 µg mLG1 vs ELF: 3.10 µg mLG1). Concentrations  found  in  AM
were also lower (54.48%) than those found in HEP-2 cells (2.79 µg mLG1) after incubation of the
cells with a dose of 280 µg mLG1 (which corresponds to an in vivo dose of 15 mg kgG1 of disodium
FOS). Tmax (4 h) was higher than that found in ELF (2.50 h), although it is lower than the Tmax
found in HEP-2 cells (12 h). Figure 2 shows the differences between FOS concentrations in AM,
ELF and HEP-2 cells. It is concluded that concentrations found in AM exceeded the MIC90 for most
pathogens  of  importance  in  pig  production  (0.25-0.50  µg  mLG1)  (Fernandez  et al.,  1995)
(T>MIC = 6 h). Therefore, FOS may be useful in the treatment of lung infections caused by
facultative intracellular microorganisms. However, it is well-known that the pathophysiological
changes induced by inflammation that occur in the lungs of infected pigs (dilation of the capillaries
and increased vascular supply to the infected region) may influence the antibiotic pharmacokinetics
in the respiratory tract of swines (Baggot, 1977; Agerso and Friis, 1998). Thus, additional studies
on FOS pharmacokinetics should be carried out in diseased pigs.
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